Dr. Jacobs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
Cc2241
Palo Alto, CA 94304Phone+1 650-725-8738Fax+1 650-498-4696
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1975 - 1977
University of California (San Francisco)Residency, Internal Medicine, 1974 - 1975
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1972 - 1974- Washington University in St. Louis School of MedicineClass of 1972
Certifications & Licensure
CA State Medical License 1974 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Fellow (FASCO) American Society of Clinical Oncologists, 2007
Clinical Trials
- A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer Start of enrollment: 2004 Apr 01
Publications & Presentations
PubMed
- 20 citationsDouble-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial o...Aarti K. Bhatia, Ju Whei Lee, Harlan A. Pinto, Charlotte Jacobs, Paul J. Limburg
Cancer. 2017-12-01 - 8 citationsPhase I and pharmacokinetic study of bexarotene in combination with gefitinib in the third-line treatment of non-small-cell lung cancer: brief report.Sukhmani K. Padda, Laveena Chhatwani, Lisa Zhou, Charlotte Jacobs, Arturo Lopez-Anaya
Anti-Cancer Drugs. 2013-08-01 - 10 citationsA phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC).J. Rodon, Charlotte Jacobs, Quincy Chu, Eric K. Rowinsky, Arturo Lopez-Anaya
Cancer Chemotherapy and Pharmacology. 2012-03-01
Grant Support
- Bexarotene In Combination With Iressa In Treatment Of Non-Small Cell Lung CancerNational Center For Research Resources2006
- Stanford University Participation In The NCOGNational Cancer Institute1985–1986
- Day Care Center--CoreNational Cancer Institute1985
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
